We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,231
Increased
3,688
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBSM icon
7176
Neuberger Small-Mid Cap ETF
NBSM
$118M
$23.8K ﹤0.01%
+956
New +$24K
ABLLW
7177
DELISTED
Abacus Life Warrant
ABLLW
$23.7K ﹤0.01%
+33,191
New +$16.4K
TOK icon
7178
iShares MSCI Kokusai Fund
TOK
$256M
$23.7K ﹤0.01%
+216
New +$23.1K
CRVS icon
7179
Corvus Pharmaceuticals
CRVS
$1.16B
$23.7K ﹤0.01%
13,000
+8,321
+178% +$15.5K
IIGD icon
7180
Invesco Investment Grade Defensive ETF
IIGD
$26.8M
$23.6K ﹤0.01%
984
+664
+208% +$15.9K
LITS
7181
Lite Strategy Inc
LITS
$32.2M
$23.6K ﹤0.01%
8,100
+3,802
+88% +$12K
HWH icon
7182
HWH International
HWH
$11.4M
$23.5K ﹤0.01%
4,615
+4,593
+20,877% +$29.7K
VRAI icon
7183
Virtus Real Asset Income ETF
VRAI
$18.3M
$23.5K ﹤0.01%
+1,020
New +$24K
RMBI icon
7184
Richmond Mutual Bancorp
RMBI
$256M
$23.5K ﹤0.01%
2,000
+1,061
+113% +$12.2K
CBIO
7185
Crescent Biopharma
CBIO
$589M
$23.4K ﹤0.01%
830
+815
+5,433% +$84.7K
RBKB icon
7186
Rhinebeck Bancorp
RBKB
$193M
$23.4K ﹤0.01%
2,974
+364
+14% +$2.84K
ZBAO
7187
Zhibao Technology Inc
ZBAO
$6.82M
$23.4K ﹤0.01%
+5,839
New +$22.2K
HYDR icon
7188
Global X Hydrogen ETF
HYDR
$99.9M
$23.3K ﹤0.01%
+892
New +$25.6K
NVOS
7189
DELISTED
Novo Integrated Sciences, Inc. Common Stock
NVOS
$23.3K ﹤0.01%
+31,062
New +$19.9K
OMH icon
7190
Ohmyhome Ltd
OMH
$3.06M
$23.2K ﹤0.01%
4,124
+3,106
+305% +$18.9K
ALUR
7191
DELISTED
Allurion Technologies
ALUR
$23.2K ﹤0.01%
930
+571
+159% +$26.3K
SOC.WS
7192
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$23.2K ﹤0.01%
+5,435
New +$19.1K
JL icon
7193
J-Long Group
JL
$20.3M
$23.1K ﹤0.01%
+4,453
New +$30.7K
DURA icon
7194
VanEck Durable High Dividend ETF
DURA
$38.6M
$23.1K ﹤0.01%
+728
New +$23.1K
OPBK icon
7195
OP Bancorp
OPBK
$233M
$23.1K ﹤0.01%
2,408
+447
+23% +$4.28K
ABOT
7196
Abacus FCF Innovation Leaders ETF
ABOT
$4.19M
$23.1K ﹤0.01%
731
+597
+446% +$17.9K
SISI
7197
DELISTED
Shineco
SISI
$23K ﹤0.01%
7
-4
-36% -$7.58K
YDEC icon
7198
FT Vest International Equity Moderate Buffer ETF December
YDEC
$164M
$23K ﹤0.01%
976
+778
+393% +$18.3K
EEA
7199
European Equity Fund
EEA
$76.3M
$23K ﹤0.01%
2,559
-1,029
-29% -$9.21K
HIBL icon
7200
Direxion Daily S&P 500 High Beta Bull 3X ETF
HIBL
$85.9M
$23K ﹤0.01%
551
-1,254
-69% -$52K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,231 new, 3,688 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,231 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.